• No results found

[PDF] Top 20 Exacerbations in the pre- and post-COPD diagnosis periods

Has 10000 "Exacerbations in the pre- and post-COPD diagnosis periods" found on our website. Below are the top 20 most common "Exacerbations in the pre- and post-COPD diagnosis periods".

Exacerbations in the pre- and post-COPD diagnosis periods

Exacerbations in the pre- and post-COPD diagnosis periods

... first diagnosis of COPD from January 1, 2005 through December 31, 2007 were identified using ICD-9 codes for chronic bronchitis, emphysema or COPD (Table ...first COPD diagnosis were ... See full document

6

Prediction models for exacerbations in patients with COPD

Prediction models for exacerbations in patients with COPD

... In order to evaluate the readiness of the prediction models for practice we defined a priori three criteria for the clinical applicability of the models. 1) Availability predictors. We deemed the set predictors in each ... See full document

13

Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio

Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio

... in COPD (admis- sions or mortality), and they can be applied to all COPD patients independently of their ...of exacerbations, hospital admissions, and mortality in stable COPD ... See full document

9

Prevention of exacerbations of COPD with pharmacotherapy

Prevention of exacerbations of COPD with pharmacotherapy

... bacterial exacerbations in patients with chronic bronchial colonisation and frequent exacerbations ...frequent exacerbations, ...stable COPD, but the magnitude of the difference was ... See full document

8

COPD exacerbations by disease severity in England

COPD exacerbations by disease severity in England

... of COPD-related admissions in the first group indicate that although patients in GOLD B incur fewer exacerbations compared to GOLD C, these are likely to be more severe and lead to hospital ...that ... See full document

13

Treatment of COPD exacerbations: antibiotics

Treatment of COPD exacerbations: antibiotics

... study was very similar to that of G UMP et al. [27] with regular follow-up visits over several years when patients are in a stable phase and additional visits at the onset of any exacerbation. However, these ... See full document

7

<p>The relationship between oral health and COPD exacerbations</p>

<p>The relationship between oral health and COPD exacerbations</p>

... Methods: We performed a case-control study of oral health among COPD exacerbators and non-exacerbators. Cases (exacerbators) had experienced ≥ 1 exacerbation in the previous 12 months, while controls ... See full document

12

Effects of Chinese medicine on patients with acute exacerbations of COPD: study protocol for a randomized controlled trial

Effects of Chinese medicine on patients with acute exacerbations of COPD: study protocol for a randomized controlled trial

... of COPD because they negatively impact health status and rates of hospitalization and readmission, and potentially result in death and functional disability [22, ...of COPD exacerbations are well ... See full document

7

Genome wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets

Genome wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets

... available COPD cases and controls (20,086 COPD cases and 215,630 ...10,523 COPD cases and 188,243 controls (UK BiLEVE ...of COPD exacerbation was additionally tested in the Lung Health Study ... See full document

32

Systolic time intervals combined with Valsalva maneuver for the diagnosis of left ventricular dysfunction in COPD exacerbations

Systolic time intervals combined with Valsalva maneuver for the diagnosis of left ventricular dysfunction in COPD exacerbations

... The patients were divided into two groups: group of patients identified as having LVD (with LVD) and a group of patients where the diagnosis of LVD was excluded (no LVD group). Variables were expressed as mean ± ... See full document

7

COPD: it is time to change!

COPD: it is time to change!

... of COPD exacerbations is a point of paramount importance in the management of COPD that needs a completely different approach because it cannot be addressed simply with the baseline pharmacological ... See full document

7

The association between recent hospitalized COPD exacerbations and adverse outcomes after percutaneous coronary intervention: a nationwide cohort study

The association between recent hospitalized COPD exacerbations and adverse outcomes after percutaneous coronary intervention: a nationwide cohort study

... without COPD, COPD patients without recent hospitalized exacerbations, and those with any exacerbation within 1 year before ...with COPD and the frequency of recent hospitalized ... See full document

11

Use of a care bundle in the emergency department for acute exacerbations of chronic obstructive pulmonary disease: a feasibility study

Use of a care bundle in the emergency department for acute exacerbations of chronic obstructive pulmonary disease: a feasibility study

... Note: COPD Outreach supported early discharge: Certain patients will continue to be assessed for suitability for early discharge within 72 hours of presenting to the eD/ AMAU by COPD Outreach ...a ... See full document

7

Th17 profile in COPD exacerbations

Th17 profile in COPD exacerbations

... some day in their life. These data lead to the belief that this disease is due to multiple factors that interact with each other. Among the most prominent are genetic factors that can condition patients to have a certain ... See full document

9

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD

... the bronchodilator effect after twice daily administration – ie, at trough FEV 1 . Furthermore, improvement in trough FEV 1 in all subgroups based on age, smoking history, COPD severity, ICS use at baseline, and ... See full document

12

Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR&lt;sup&gt;&amp;reg;&lt;/sup&gt; trial

Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR<sup>&reg;</sup> trial

... many COPD exacerbations occurred in winter than in summer (representing ...in exacerbations in winter vs summer, with 28.5% of all exacerbations occurring in winter and ... See full document

12

Impact of exacerbations on COPD

Impact of exacerbations on COPD

... of COPD exacerbations may potentially impair lung tissues and lead to an accelerated rate of decline in pulmonary ...1) Exacerbations are associated with transient decreases in pulmonary function ... See full document

6

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD

... one pre- scription in the 60 days before the event date) and past users (at least one prescription in the year before the event date but no prescription in the 60 days before the event date) and used nonusers as ... See full document

10

Home telemonitoring for patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial

Home telemonitoring for patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial

... with COPD typic- ally worsen over time and experience episodes of acute exacerbation (AE) [1] which are crucially important in patient management in view of their negative effect on Quality of Life (QoL) and ... See full document

12

&lt;p&gt;Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study&lt;/p&gt;

<p>Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study</p>

... with COPD. COPD indicators (pneumonia, other respiratory diseases, oral corticosteroids, antibiotics for respiratory infections, prescribed drugs for respiratory symptoms, lung function measure- ment) ... See full document

14

Show all 10000 documents...